Inhibition of Viral Fusion by Interferon-Induced Transmembrane Proteins

Xiangyang Guo,Jan Steinkuehler,Mariana Marin,Rumiana Dimova,Gregory Melikian
DOI: https://doi.org/10.1016/j.bpj.2020.11.093
IF: 3.4
2021-01-01
Biophysical Journal
Abstract:Interferon-induced transmembrane proteins (IFITMs) are small type II membrane proteins exhibiting a remarkably broad activity against diverse enveloped viruses. Expression of IFITMs blocks infection by inhibiting virus-cell fusion, however, the mechanism by which these proteins interfere with virus entry remains unclear. Using single virus tracking in living cells, we have demonstrated that IFITM3, the member of IFITM family that is localized to endosomes, is concentrated at the sites of the influenza virus entry and blocks viral fusion with endosomes at a hemifusion intermediate. This finding strongly supports a direct mechanism of inhibition of membrane fusion by IFITM3. To further delineate the mechanism of IFITM3's antiviral activity, we purified and reconstituted a full-length recombinant IFITM3 into giant unilamellar vesicles (GUVs) and demonstrated its ability to induce negative curvature (inward vesicle budding). The membrane bending activity of IFITM3 mapped to the short amphipathic helix (AH) corresponding to the residues 59-68 of the cytoplasmic region, which has been shown to be essential for the antiviral activity. in contrast, mutations in the AH peptides shown to compromise the IFITM3's activity through disrupting the amphipathic helix, rendered AH incapable of promoting the formation of intralumenal vesicles. As expected, a negative curvature imposed by addition of AH was antagonized by inclusion of a positive curvature-inducing lipid lyso-phosphatidylcholine. Importantly, we found that AH increases the lipid order and membrane bending modulus of lipid bilayers. Together, these effects of IFITM3 and the AH peptide – induction of negative curvature and stiffening of lipid membranes – are expected to disfavor membrane fusion by stabilizing the hemifusion diaphragm. We propose a model according to which IFITM3 accumulates at sites of virus-endosome fusion and inhibits the transition from hemifusion to full fusion by modulating the properties of the cytoplasmic leaflet of endosomal membrane.
What problem does this paper attempt to address?